On Biostatistics and Clinical Trials
CQ's web blog on the issues in biostatistics and clinical trials.
Showing posts with label
Day 74 letter
.
Show all posts
Showing posts with label
Day 74 letter
.
Show all posts
Saturday, March 11, 2023
Critical Dates after NDA/BLA submission: Filing Date (Day 1), Day 14, Day 60, Day 74, and PDUFA date
›
After the NDA/BLA is submitted to FDA, the FDA review clock starts. There are several critical dates relevant to the applicant (the sponsor)...
3 comments:
›
Home
View web version